Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 6,658 clinical trials worldwide
Search
Showing 1-50 of 6,658 trials
Active filters:
Phase: Phase 1
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (6,658)
NCT06708767
Safety Study of CZ10 in Healthy Volunteers
PHASE1
Not yet recruiting
24 participants
Started: Jan 31, 2050 · Completed: Jan 31, 2054
1 condition
1 sponsor
0 locations
NCT05662904
Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML
PHASE1
Not yet recruiting
12 participants
Started: Jan 31, 2028 · Completed: Jan 31, 2030
1 condition
3 sponsors
2 locations
NCT04933422
CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM)
PHASE1
Not yet recruiting
72 participants
Started: Jan 31, 2027 · Completed: Jul 31, 2029
1 condition
1 sponsor
0 locations
NCT06839729
Addressing Parental Tobacco Use in Somali Immigrant Families: Adapting an Evidence-Based Intervention in Primary Care
PHASE1
Not yet recruiting
50 participants
Started: Jan 1, 2027 · Completed: Dec 31, 2029
2 conditions
1 sponsor
0 locations
NCT04903795
Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma
PHASE1
Not yet recruiting
18 participants
Started: Dec 31, 2026 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT04366115
Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS
PHASE1
Not yet recruiting
16 participants
Started: Dec 1, 2026 · Completed: Mar 1, 2032
3 conditions
2 sponsors
0 locations
NCT05048368
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
PHASE1
Not yet recruiting
32 participants
Started: Oct 30, 2026 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
NCT06881888
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
PHASE1
Not yet recruiting
60 participants
Started: Aug 31, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06600880
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
PHASE1
Not yet recruiting
6 participants
Started: Aug 31, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04035629
129Xe MRI in Pediatric Population With BPD
PHASE1
Not yet recruiting
30 participants
Started: Aug 1, 2026 · Completed: Dec 31, 2031
1 condition
2 sponsors
1 location
NCT06647277
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
PHASE1
Not yet recruiting
10 participants
Started: Jul 31, 2026 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06955130
Lactate and Glycerol Contribution to Gluconeogenesis
PHASE1
Not yet recruiting
48 participants
Started: Jul 1, 2026 · Completed: Apr 30, 2030
3 conditions
1 sponsor
0 locations
NCT07203898
A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.
PHASE1
Not yet recruiting
36 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2027
1 condition
1 sponsor
0 locations
NCT07137338
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
PHASE1
Not yet recruiting
8 participants
Started: Jun 30, 2026 · Completed: Jun 30, 2029
1 condition
1 sponsor
0 locations
NCT06297213
R-2487 in Patients With Sjogren's Syndrome (SS)
PHASE1
Not yet recruiting
36 participants
Started: Jun 1, 2026 · Completed: Aug 30, 2028
3 conditions
1 sponsor
0 locations
NCT04419909
Retreatment With CTL019/CTL119
PHASE1
Not yet recruiting
12 participants
Started: May 31, 2026 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT06996119
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
PHASE1
Not yet recruiting
15 participants
Started: May 25, 2026 · Completed: May 25, 2027
3 conditions
2 sponsors
1 location
NCT06325150
The Impact of Light Exposure on Cognitive Function in Classrooms
PHASE1
Not yet recruiting
300 participants
Started: May 16, 2026 · Completed: Feb 1, 2028
1 condition
1 sponsor
1 location
NCT07020533
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
PHASE1
Not yet recruiting
46 participants
Started: May 8, 2026 · Completed: Jun 1, 2027
12 conditions
2 sponsors
3 locations
NCT06012487
Correlates and Control of Blood Pressure Variability
PHASE1
Not yet recruiting
10 participants
Started: May 1, 2026 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT07218549
Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid Use
PHASE1
Not yet recruiting
50 participants
Started: May 1, 2026 · Completed: May 31, 2029
3 conditions
2 sponsors
1 location
NCT07040982
Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
PHASE1
Not yet recruiting
30 participants
Started: May 1, 2026 · Completed: Jun 13, 2028
1 condition
2 sponsors
1 location
NCT06802523
Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia
PHASE1
Recruiting
53 participants
Started: Apr 21, 2026 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06507904
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
PHASE1
Not yet recruiting
52 participants
Started: Apr 17, 2026 · Completed: Oct 31, 2026
1 condition
1 sponsor
0 locations
NCT05093972
Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)
PHASE1
Not yet recruiting
22 participants
Started: Apr 7, 2026 · Completed: Sep 10, 2026
1 condition
1 sponsor
0 locations
NCT05238961
Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy
PHASE1
Recruiting
20 participants
Started: Apr 1, 2026 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT03258658
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
PHASE1
Recruiting
10 participants
Started: Mar 31, 2026 · Completed: Dec 31, 2029
4 conditions
2 sponsors
2 locations
NCT06746831
Methamphetamine Isomer Pharmacology in Humans
PHASE1
Not yet recruiting
17 participants
Started: Mar 31, 2026 · Completed: Mar 31, 2028
1 condition
2 sponsors
1 location
NCT07183852
Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma
PHASE1
Not yet recruiting
18 participants
Started: Mar 31, 2026 · Completed: Mar 31, 2033
2 conditions
1 sponsor
0 locations
NCT03463239
Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora
PHASE1
Not yet recruiting
10 participants
Started: Mar 31, 2026 · Completed: Jul 31, 2027
6 conditions
2 sponsors
1 location
NCT05038098
Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
PHASE1
Not yet recruiting
20 participants
Started: Mar 31, 2026 · Completed: Feb 2, 2027
1 condition
1 sponsor
1 location
NCT07187869
Modulation of the Bone Immune Microenvironment Following Cabozantinib Treatment of Bone Metastatic Clear Cell Renal Cell Carcinoma: Proof of Concept Study
PHASE1
Not yet recruiting
16 participants
Started: Mar 31, 2026 · Completed: Apr 7, 2029
1 condition
2 sponsors
0 locations
NCT03606538
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
PHASE1
Not yet recruiting
16 participants
Started: Mar 29, 2026 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT06148038
CBD for Breast Cancer Primary Tumors
PHASE1
Not yet recruiting
60 participants
Started: Mar 1, 2026 · Completed: Jan 1, 2028
1 condition
1 sponsor
0 locations
NCT05976555
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
PHASE1
Not yet recruiting
30 participants
Started: Mar 1, 2026 · Completed: May 31, 2029
1 condition
1 sponsor
0 locations
NCT07041203
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
PHASE1
Not yet recruiting
8 participants
Started: Mar 1, 2026 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT05094011
Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease
PHASE1
Not yet recruiting
9 participants
Started: Mar 1, 2026 · Completed: Jul 31, 2028
1 condition
1 sponsor
0 locations
NCT07199413
Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases
PHASE1
Not yet recruiting
20 participants
Started: Mar 1, 2026 · Completed: Apr 1, 2029
2 conditions
1 sponsor
0 locations
NCT06649864
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
PHASE1
Not yet recruiting
20 participants
Started: Feb 28, 2026 · Completed: Jun 30, 2028
2 conditions
1 sponsor
1 location
NCT07204171
Phase 1 Study of Oral MG001
PHASE1
Not yet recruiting
32 participants
Started: Feb 28, 2026 · Completed: Aug 31, 2026
1 condition
3 sponsors
1 location
NCT07025564
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1
Recruiting
12 participants
Started: Feb 28, 2026 · Completed: Apr 8, 2027
2 conditions
2 sponsors
1 location
NCT06978062
Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
PHASE1
Not yet recruiting
27 participants
Started: Feb 20, 2026 · Completed: Sep 28, 2029
1 condition
1 sponsor
0 locations
NCT07101432
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
PHASE1
Not yet recruiting
33 participants
Started: Feb 8, 2026 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT06859008
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1
Recruiting
37 participants
Started: Feb 7, 2026 · Completed: Jan 31, 2029
19 conditions
2 sponsors
1 location
NCT07218913
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
PHASE1
Not yet recruiting
44 participants
Started: Feb 4, 2026 · Completed: Feb 17, 2030
7 conditions
2 sponsors
1 location
NCT06886737
Home-based Vision Therapy
PHASE1
Not yet recruiting
45 participants
Started: Feb 2, 2026 · Completed: Sep 30, 2028
1 condition
1 sponsor
1 location
NCT07053319
SGLT2i, Pioglitazone, and Ketone Production in T2D
PHASE1
Recruiting
64 participants
Started: Feb 1, 2026 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT07016971
CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy
PHASE1
Not yet recruiting
12 participants
Started: Feb 1, 2026 · Completed: May 1, 2029
1 condition
1 sponsor
1 location
NCT06953388
Understanding Non-invasive Vagus Nerve Stimulation Effects in PTSD
PHASE1
Not yet recruiting
60 participants
Started: Feb 1, 2026 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT07218367
Phase I Trial of pH Resections of GBM at VA
PHASE1
Not yet recruiting
12 participants
Started: Feb 1, 2026 · Completed: Feb 1, 2031
1 condition
2 sponsors
1 location
«
Previous
1
2
2
3
4
More pages
134
Next